WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2016097030) PHARMACEUTICAL COMPOSITION COMPRISING AMORPHOUS LENALIDOMIDE
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2016/097030    International Application No.:    PCT/EP2015/080060
Publication Date: 23.06.2016 International Filing Date: 16.12.2015
IPC:
A61K 9/14 (2006.01), A61K 9/16 (2006.01), A61K 31/454 (2006.01)
Applicants: SYNTHON B.V. [NL/NL]; Microweg 22 6545 CM Nijmegen (NL)
Inventors: MURPANI, Deepak; (NL).
VIVANCOS MARTINEZ, Marta; (ES).
ÁLVAREZ FERNÁNDEZ, Lisardo; (ES).
NOGUEIRAS NIETO, Luis; (ES)
Agent: MENDIVIL-GIL, Maria Dolores; (NL)
Priority Data:
PCT/EP2014/078824 19.12.2014 EP
Title (EN) PHARMACEUTICAL COMPOSITION COMPRISING AMORPHOUS LENALIDOMIDE
(FR) COMPOSITION PHARMACEUTIQUE COMPRENANT DU LENALIDOMINE AMORPHE
Abstract: front page image
(EN)The present invention relates to a pharmaceutical composition comprising an amorphous adsorbate of lenalidomide, or a pharmaceutically acceptable salt thereof, on a porous carrier and one or more pharmaceutically acceptable excipients. The invention further relates to the use of said composition as a medicament, particularly in the treatment of multiple myeloma and myelodyplastic syndromes.
(FR)La présente invention concerne une composition pharmaceutique comprenant un adsorbat amorphe du lenalidomide, ou un sel pharmaceutiquement acceptable de celui-ci, sur un substrat poreux et un ou plusieurs excipients pharmaceutiquement acceptables. L'invention concerne également l'utilisation de ladite composition comme médicament, notamment dans le traitement d'un myélome multiple et des syndromes myélodysplastiques.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)